Patents
Patents for C07K 19 - Hybrid peptides (29,428)
07/2006
07/11/2006US7074899 A polypeptides, polynucleotides, gene expression host cells, use in drug screening and diagnosis of potential agonists, antagonists
07/11/2006US7074620 Controlling protein levels in eucaryotic organisms
07/11/2006US7074614 Clock gene BMAL2
07/11/2006US7074411 α-β C4BP-type recombinant heteromultimeric proteins
07/11/2006US7074408 Use of integrin antagonists to inhibit angiogenesis
07/11/2006US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells
07/11/2006CA2176463C Hu-b1.219, a novel human hematopoietin receptor
07/11/2006CA2117536C Immunological detection of organophosphates
07/06/2006WO2006044410A3 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines
07/06/2006US20060149482 Nucleic acids and proteins with thioredoxin reductase activity
07/06/2006US20060149039 Pseudo-native chemical ligation
07/06/2006US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof
07/06/2006US20060148017 Compositions and methods for monitoring enzyme activity
07/06/2006US20060147444 Biosynthetic binding proteins for immuno-targeting
07/06/2006DE102004062420A1 Verfahren zur Isolierung neuraler Zellen mit Tenascin-R-Verbindungen Method for the isolation of neural cells with tenascin-R compounds
07/06/2006CA2589374A1 Antibodies directed to gpnmb and uses thereof
07/05/2006EP1676920A2 Anticoagulant fusion protein anchored to cell membrane
07/05/2006EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase
07/05/2006EP1675579A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses
07/05/2006EP1214344B1 Dipeptidyl peptidases
07/05/2006EP1107979B1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
07/05/2006EP0702725B1 Method for recombinant production of biologically active polypeptides
07/05/2006CN1798770A Peptabody for cancer treatment
07/05/2006CN1796417A Technique for purifying engineering fusion antigen of containing S (main protein) and previous SI (large protein) hepatitis B surface gene
07/05/2006CN1796414A New alpha - conantokins, coded polynucleotide and application
07/05/2006CN1796413A New T - ultra family conantokins, coded polynucleotide and application
07/05/2006CN1262565C Recombinant fusion protein for diagnosis of tsutsugamushi disease
07/04/2006US7071307 Nucleic acids and proteins with thioredoxin reductase activity
07/04/2006US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof
07/04/2006US7070785 Heat shock proteins for use in enhancing cellular factor production
07/04/2006US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
06/2006
06/29/2006WO2006069262A2 Compositions of influenza viral proteins and methods of use thereof
06/29/2006WO2006068187A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
06/29/2006WO2006066596A2 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence
06/29/2006WO2006066358A1 Vacuole targeting peptide and nucleic acid
06/29/2006WO2006036834A3 MODIFIED Fc MOLECULES
06/29/2006WO2006027468A3 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof
06/29/2006WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
06/29/2006US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases
06/29/2006US20060141579 Cytokine zcytor17 ligand polynucleotides
06/29/2006US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
06/29/2006US20060140979 Antigenic polypeptides
06/29/2006US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation
06/29/2006US20060140931 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
06/29/2006CA2594053A1 Vacuole targeting peptide and nucleic acid
06/29/2006CA2593746A1 Compositions of influenza viral proteins and methods of use thereof
06/29/2006CA2592083A1 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence
06/29/2006CA2591871A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
06/28/2006EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use
06/28/2006EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
06/28/2006EP0712414B1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
06/28/2006CN1795209A Cleavage of fusion proteins using granzyme b protease
06/28/2006CN1793179A Optimizing fusion protein containing VEGF recerver segment and medical application thereof
06/28/2006CN1793178A Fusion protein of tetanus toxin T cell expressing bit polypeptide and human bata lymph cell stimulating factor and preparing thereof
06/28/2006CN1793176A Rat's IL-17RE span film region and cell inner region poly peptide and coding sequence, fusion protein and clone
06/28/2006CN1793169A Sea snail toxin variant polypeptide compound, its preparation process and application thereof
06/28/2006CN1261570C Actinia neurotoxin gene and its application
06/27/2006US7067639 Method to provide bacterial ghosts provided with antigens
06/27/2006US7067629 Sodium channel in dorsal root ganglia
06/27/2006US7067617 Polypeptides for use in artifically controlling gene expression
06/27/2006US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein
06/22/2006WO2006012415A3 Rage protein derivatives
06/22/2006US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
06/22/2006US20060135431 Peptides and related molecules that bind to TALL-1
06/22/2006US20060135428 kringle peptides; peptidase stabilized
06/22/2006US20060134655 Introducing a polynucleotide expressing a cGMP-visualizing probe into cells, whereby the cGMP-visualizing probe is expressed and made to coexist with cGMP; measuring the change in fluorescence wavelength
06/22/2006CA2587589A1 Engineered antibodies and immunoconjugates
06/21/2006EP1672068A1 A method of affinity separation and ligands for use therein
06/21/2006EP1670813A2 Rho antibody and tag to purify cell surface proteins
06/21/2006EP1252315B1 Method for the production of a protein
06/21/2006EP1189931B1 Peptide compounds that bind her2
06/21/2006EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
06/21/2006CN1789424A Dual target effected chimera recombinant, its construction method and application
06/21/2006CN1260367C Fortified fusion protein possessing angiopoiesis-inhibiting and anti-tumour actions
06/20/2006US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/20/2006US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases
06/20/2006US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders
06/20/2006US7064185 Antibody for human Cyr61
06/20/2006US7063966 Quantitative analysis; complexing with antibodies
06/20/2006US7063841 Mammalian cell surface antigens; related reagents
06/15/2006WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature
06/15/2006US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP)
06/15/2006US20060127989 Antigenic fragment of human T-lymphotropic virus
06/15/2006US20060127937 Novel Survivin interacting protein TPR1
06/15/2006US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines
06/15/2006US20060127389 Fused protein with the function of both hemolysis and anticoagulation and use of it
06/15/2006US20060127361 Compositions and methods for inducing gene expression
06/14/2006EP1668122A2 Construction of a gst-cbd fusion protein having several enzymatic activities
06/14/2006EP1668037A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain
06/14/2006EP1379650B1 Preferred segments of neural thread protein and methods of using the same
06/14/2006EP1071468B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
06/14/2006CN1786173A Antidisense immune and bactericidal function fusion protein hcml gene and its protein
06/14/2006CN1786032A Erythrogenin/immune globulin Fc fusion protein, its sypthesis method and application
06/14/2006CN1259420C Sea anemone neurotoxin gene Sr3 and application thereof
06/14/2006CN1259419C Sea anemone neurotoxin gene Sr2 and application thereof
06/14/2006CN1259340C Peptide composition as immunogen for treatment of allergy
06/13/2006US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
06/13/2006US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases.
06/13/2006US7060495 Polypeptide for use in as anticarcinogenic agent
06/13/2006US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain